Novanta Inc

Novanta Inc(NOVT)股票分析

$144.020

+3.298 (+2.29%)收盤時

Loading chart…
最高
146.330
開盤
141.330
成交量加權均價
143.88
成交量
373.90K
市值
—
最低
141.290
成交金額
53.80M
企業價值/稅息折舊攤銷前利潤(TTM)
22.99

Novanta Inc. is a supplier of core technology solutions, which offer medical and advanced industrial original equipment manufacturers. Its segment includes Automation Enabling Technologies and Medical Solutions. The Automation Enabling Technologies segment designs, manufactures and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision motors, integrated stepper motors, servo drives, motion control solutions, intelligent robotic end-of-arm technology solutions, and air bearing spindles to customers worldwide. The Medical Solutions segment designs, manufactures and markets a range of medical grade technologies, including medical insufflators and endoscopic pumps and related disposables, laser beam delivery solutions, video processing and streaming and capture, machine vision technologies, radio frequency identification (RFID) technologies, thermal chart recorders, and others.

AI 分析 of Novanta Inc (NOVT)

買進

Novanta Inc. (NOVT) is a good buy right now, trading at $140.80 with a forward P/E ratio of 8.39, indicating strong earnings potential relative to its price. The stock has shown a 5-day change of +9.33%, suggesting positive momentum. However, insider selling has increased by 134.30%, which is a risk to consider.

分析師評級(1)

買進
1 買進
0 持有
0 賣出
目前: 144.02
最低
—
平均
—
最高
—

Baird

2026-08-07

目標價

$194

優於大盤

Baird

2026-05-13

目標價

$173

優於大盤

Baird

2026-03-30

目標價

$144

優於大盤

Baird

2026-02-25

目標價

$150

中性

Baird

2025-08-11

目標價

$133

中性

估值指標

Novanta Inc(NOVT)目前預期本益比為 8.39,5 年平均預期本益比為 39.24。

預期本益比

嚴重低估
5 年均值 P/E
39.24
目前P/E
8.39
高估
54.33
低估
24.14

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
26.84
目前EV/EBITDA
22.99
高估
31.20
低估
22.47

預期股價營收比

低估
5 年均值 P/S
5.42
目前P/S
4.05
高估
6.38
低估
4.47

Alphio AI 對 NOVT 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%NOVT

$155.23

情境價格

基

基準

基準 · 50%NOVT

$145.52

情境價格

悲

悲觀

悲觀 · 25%NOVT

$116.12

情境價格

持有 NOVT 的大戶

B

Baron Capital Group, Inc.

+ 持有NOVT

+13.36%

3個月報酬率

A

Allspring Global Investments, LLC

+ 持有NOVT

+8.85%

3個月報酬率

A

American Capital Management, Inc.

+ 持有NOVT

+8.15%

3個月報酬率

O

Osterweis Capital Management, Inc.

+ 持有NOVT

+4.82%

3個月報酬率

O

Oberweis Asset Management, Inc.

+ 持有NOVT

+2.87%

3個月報酬率

D

Delaware Management Company

+ 持有NOVT

+2.12%

3個月報酬率

事件時間軸

2026-08-05 (ET)

17:00:00

Novanta Reports Q2 Revenue of $265.8 Million

17:00:00

Sees FY26 Revenue of $1.13B-$1.14B

17:00:00

Sees Q3 Revenue of $300M-$304M

2026-07-27 (ET)

08:30:00

Novanta Completes Acquisition of Riverpoint Medical

2026-06-29 (ET)

17:30:00

Selling Stockholders Plan to Sell 2.14M Common Shares

資訊

NOVT 常見問題 —— 由 Alphio AI 解答

Novanta Inc. is a supplier of core technology solutions, which offer medical and advanced industrial original equipment manufacturers. Its segment includes Automation Enabling Technologies and Medical Solutions. The Automation Enabling Technologies segment designs, manufactures and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision motors, integrated stepper motors, servo drives, motion control solutions, intelligent robotic end-of-arm technology solutions, and air bearing spindles to customers worldwide. The Medical Solutions segment designs, manufactures and markets a range of medical grade technologies, including medical insufflators and endoscopic pumps and related disposables, laser beam delivery solutions, video processing and streaming and capture, machine vision technologies, radio frequency identification (RFID) technologies, thermal chart recorders, and others. It operates in the Technology sector (MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SU industry).

Novanta Inc. (NOVT) is a good buy right now, trading at $140.80 with a forward P/E ratio of 8.39, indicating strong earnings potential relative to its price. The stock has shown a 5-day change of +9.33%, suggesting positive momentum. However, insider selling has increased by 134.30%, which is a risk to consider.

1 analysts cover NOVT: 1 rate it Buy, 0 Hold and 0 Sell.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易